Trial Profile
A Double-Blind Placebo-Controlled Preliminary Study of the Efficacy, Safety and Tolerability of ST101 Tablets in the Treatment of Alzheimer's Disease in Subjects Concurrently Receiving Donepezil (Aricept).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs ST 101 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 06 Jun 2012 Actual patient number is 210 according to ClinicalTrials.gov.
- 19 Aug 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 19 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.